RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CR at 450Consultant99 ... We already had/have some answers from NML so far.
Will it be quicker to make? sounds like yes as per a comment by Dr. Kobasa Will it be cheaper to make store and transport? sounds like yes Will it have greater efficacy? sounds like yes, given it destroys the virus envelopes Will it be safer? yes given the low dose (nano molecular dose) hinted by Dr. Coombs and Dr. Kobasa How adaptable to other viruses? yes as per the comment by Dr. Kobasa mentioned in the press releases _________________________
consultant99 - (7/25/2022 12:38:38 PM)
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CR at 450
There is a lot of potential - I 100% totally agree with you. It might not be enough to just be able to make a vaccine that works but how this novel approach compares to existing vaccines.
Will it be quicker to make?
Will it be cheaper to make store and transport?
Will it have greater efficacy?
Will it be safer?
How adaptable to other viruses?
NVAX share price went from less than $5/share to over $300 briefly during the Covid vaccine gold rush. It is not hard to imagine TLT getting a big share price boost if the current animal testing is favourable and leads to human testing of a Covid vaccine.
The next 6-9 months could be liftoff with BTD AA for bladder cancer and moving towards human testing of a Covid vaccine. Will Roger be driving the bus by then?